Mark S Wallace Selected Research

ziconotide (Prialt)

9/2010	Ziconotide combination intrathecal therapy: rationale and evidence.
1/2010	Considerations and methodology for trialing ziconotide.
9/2009	Intrathecal ziconotide for neuropathic pain: a review.
3/2009	Long-term intrathecal ziconotide for chronic pain: an open-label study.
4/2008	Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
2/2008	Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial.
1/2008	Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study.
10/2006	Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
5/2006	A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.
4/2006	Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark S Wallace Research Topics

Disease

57	Pain (Aches) 01/2022 - 01/2002
15	Neuralgia (Stump Neuralgia) 01/2022 - 06/2002
15	Chronic Pain 01/2021 - 05/2006
13	Hyperalgesia 01/2017 - 01/2002
9	Neoplasms (Cancer) 11/2021 - 01/2004
9	Dizziness (Lightheadedness) 09/2013 - 04/2006
7	Postherpetic Neuralgia 10/2015 - 05/2006
5	Sleepiness 09/2013 - 03/2009
5	Cancer Pain 10/2012 - 09/2010
4	Intractable Pain 01/2012 - 09/2002
3	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 02/2007
3	Nausea 09/2013 - 04/2006
3	Confusion (Bewilderment) 09/2009 - 05/2006
2	Neck Pain (Cervicalgia) 01/2022 - 11/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 01/2019
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2020 - 01/2019
2	Low Back Pain (Lumbago) 01/2020 - 01/2016
2	Breast Neoplasms (Breast Cancer) 06/2017 - 12/2015
2	Breakthrough Pain 03/2014 - 07/2012
2	Fatigue 09/2013 - 02/2007
2	Headache (Headaches) 09/2013 - 01/2010
2	Ataxia (Dyssynergia) 01/2012 - 05/2006
2	Urinary Retention 09/2009 - 04/2006
2	Vomiting 09/2009 - 04/2006
1	Inflammation (Inflammations) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 11/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Prescription Drug Misuse 01/2021
1	Cognitive Dysfunction 11/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Marijuana Use 01/2019
1	Chronic Disease (Chronic Diseases) 02/2017
1	Hypersensitivity (Allergy) 01/2017
1	Acute Pain 02/2016
1	Postoperative Pain 01/2015
1	Edema (Dropsy) 09/2013
1	Shoulder Pain 05/2012
1	Failed Back Surgery Syndrome 07/2011
1	Death (Near-Death Experience) 05/2011
1	Nociceptive Pain 05/2011
1	Procedural Pain 11/2010

Drug/Important Bio-Agent (IBA)

15	Opioid Analgesics (Opioids)IBA 12/2021 - 11/2002
15	Analgesics (Analgesic Drugs)IBA 01/2017 - 01/2002
13	Capsaicin (Zostrix)FDA Link 12/2021 - 01/2002
11	Pharmaceutical PreparationsIBA 06/2015 - 09/2002
11	ziconotide (Prialt)FDA Link 09/2010 - 01/2004
9	Gabapentin (Neurontin)FDA LinkGeneric 01/2016 - 11/2003
4	Alfentanil (Alfenta)FDA LinkGeneric 12/2021 - 01/2002
4	Medical MarijuanaIBA 11/2021 - 01/2019
4	Morphine (MS Contin)FDA LinkGeneric 09/2010 - 10/2006
3	Pregabalin (Lyrica)FDA Link 12/2021 - 06/2006
3	Ropivacaine (Naropin)FDA LinkGeneric 06/2017 - 03/2014
3	Local AnestheticsIBA 06/2017 - 01/2015
3	Fentanyl (Sublimaze)FDA LinkGeneric 07/2012 - 09/2010
3	TabletsIBA 07/2012 - 01/2010
3	SteroidsIBA 05/2012 - 05/2007
3	Lidocaine (Xylocaine)FDA LinkGeneric 11/2010 - 11/2003
2	Opiate AlkaloidsIBA 01/2022 - 01/2016
2	CannabinoidsIBA 11/2021 - 07/2015
2	Saline SolutionIBA 06/2017 - 01/2015
2	N 30IBA 01/2015 - 03/2014
2	Adenosine Diphosphate (ADP)IBA 08/2013 - 01/2010
2	Calcium Channels (Calcium Channel)IBA 09/2011 - 01/2004
2	Desipramine (Pertofrane)FDA LinkGeneric 04/2007 - 10/2002
2	2,4- diamino- 5- (2,3- dichlorophenyl)- 6- fluoromethylpyrimidineIBA 06/2004 - 06/2002
2	Sodium Channels (Sodium Channel)IBA 06/2004 - 06/2002
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2003 - 10/2002
2	Ketamine FDA LinkGeneric 11/2002 - 01/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	CannabidiolIBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 11/2020
1	Technetium (Technetium 99m)IBA 12/2015
1	Technetium Tc 99m Sulfur Colloid FDA Link 12/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2013
1	tezampanelIBA 12/2012
1	ProdrugsIBA 12/2012
1	Kainic Acid (Kainate)IBA 12/2012
1	Kainic Acid Receptors (Kainate Receptor)IBA 12/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 12/2012
1	AcidsIBA 12/2012
1	Hydromorphone (Dilaudid)FDA LinkGeneric 09/2012
1	Anesthetics (Anesthetic Agents)IBA 11/2010
1	SaltsIBA 11/2010
1	Tetracaine (Amethocaine)FDA LinkGeneric 11/2010

Therapy/Procedure

12	Therapeutics 01/2019 - 09/2002
6	Analgesia 06/2017 - 01/2004
5	Injections 01/2022 - 05/2007
4	Conduction Anesthesia (Regional Anesthesia) 01/2022 - 06/2017
4	Nerve Block (Nerve Blocks) 01/2022 - 03/2014
4	Drug Therapy (Chemotherapy) 01/2019 - 09/2002
3	Radiofrequency Ablation 01/2022 - 01/2020
2	Catheters 06/2017 - 01/2015
2	Mastectomy (Mammectomy) 06/2017 - 01/2015
2	Pain Management 05/2011 - 11/2010
1	Palliative Care (Palliative Therapy) 11/2021
1	Infusion Pumps (Infusion Pump) 07/2014
1	Polypharmacy 09/2011
1	Spinal Cord Stimulation 07/2011
1	Anesthesia 11/2010